Joint RUSSCO-ASTRO-SPRO Session on Palliative Radiation Therapy in Incurable Patients: Keeping symptoms down and hope high-AM2019
Forty percent of radiation therapy in the United States is given with palliative intent. At the same time, palliative RT receives disproportionately low attention at national meetings, is not well studied on clinical protocols. Palliative RT remains more of an art than clinical science.
Category
  • Palliative Care
Format
  • Online SA-CME
Credits
  • SA-CME
  • Certificate of Attendance
RO-ILS Quarters 1 and 2 2018 Aggregate Report
RO-ILS: Radiation Oncology Incident Learning System® Quarters 1 and 2 2018 Aggregate Report analyzes common errors that occur while treating patients in radiation onco
Category
  • Patient Safety
Format
  • CME only
  • RO-ILS
Credits
  • AMA PRA Category 1 Credit™
  • Certificate of Attendance
Immunotherapies in Combination with Radiation Therapy: Optimal Study Design - AM2019
This workshop was developed in collaboration between ASTRO and Society for Immunotherapy of Cancer (SITC). The workshop provides examples of different settings and study design to test currently available commercial immunotherapies combined with radiation therapy.
Category
  • Other
Format
  • Online SA-CME
Credits
  • SA-CME
  • Certificate of Attendance
RO-ILS Quarter 2 2017 Aggregate Report
RO-ILS: Radiation Oncology Incident Learning System® Quarter 2 2017 Aggregate Report analyzes common errors
Category
  • Patient Safety
Format
  • CME only
  • RO-ILS
Credits
  • AMA PRA Category 1 Credit™
  • Certificate of Attendance
Gray Zone-Optimizing Rectal Cancer Neoadjuvant Therapy – How to Manage a cCR?
The ultimate goal of radiation oncology research is to improve clinical care.  As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.  But despite our best efforts, evidence-based medicine cannot provide 1 clear
Category
  • Genitourinary Cancer
Format
  • CME only
Credits
  • AMA PRA Category 1 Credit™
Radiation dose escalation or longer androgen suppression to prevent distant progression in men with locally advanced prostate cancer?
This journal activity provides practitioners with prospective data supporting the use of longer term ADT in men with high-risk prostate cancer even if they are receiving high dose EBRT of HDR brachytherapy.
Category
  • Genitourinary Cancer
Format
  • Journal SA-CME
Credits
  • SA-CME
  • Certificate of Attendance

Pages